Nanoligent Sl
The research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.
Launch date
Employees
Market cap
-
Enterprise valuation
€11—17m (Dealroom.co estimates Sep 2022.)
Company register number B66970088
Cerdanyola del Vallès Catalonia (HQ)
Authorizing premium user...